Independence Blue Cross to Pay $22.5 Million Over Medicare Advantage Diagnosis Allegations
Independence Blue Cross has agreed to pay $22.5 million to settle allegations that it kept Medicare money tied to diagnosis codes that its own medical-record reviews did not support. The Justice Department announced the settlement Wednesday, bringing a civil False Claims Act case against the Pennsylvania insurer to a close without a determination of liability. The allegations concern Independence Blue Cross, or IBX, and its Medicare Advantage business during payment years 2017 through 2021.
